Expanding International Presence Recent partnerships, such as with AKVA Surgical in Australia, indicate opportunities to target additional international markets where BONESUPPORT's products can address unmet needs in bone defect treatment.

Innovative Product Launches The launch of next-generation CERAMENT G and specialized products like CERAMENT BONE VOID FILLER for osteomyelitis highlight ongoing innovation, creating chances to upsell new solutions to existing clients seeking advanced bone healing therapies.

Strategic Healthcare Partnerships Collaborations with organizations like OrthoPediatrics and the Department of Veterans Affairs suggest a strong foothold in pediatric and military healthcare sectors, which can be leveraged for targeted outreach and expanding patient case volume.

Growth Through Funding With recent funding of $39 million and revenue between $10 million and $25 million, there is potential to invest in sales and marketing efforts for increased market penetration and to reach new orthopedic and trauma treatment centers.

Market Preference for Bioceramics The focus on radiopaque, osteoconductive, drug-eluting bioceramic products positions BONESUPPORT as a preferred provider for hospitals and surgeons seeking innovative, effective solutions for complex bone repairs, increasing sales opportunities in these targeted clinical areas.